The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADMA BIOLOGICS INC | COM | 000899104 | 876 | 497,842 | SH | SOLE | 497,842 | 0 | 0 | ||
AKUMIN INC | COM | 01021F109 | 1,588 | 429,061 | SH | SOLE | 429,061 | 0 | 0 | ||
ALBIREO PHARMA INC | COM | 01345P106 | 6,005 | 170,352 | SH | SOLE | 170,352 | 0 | 0 | ||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 5,625 | 473,446 | SH | SOLE | 473,446 | 0 | 0 | ||
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 1,328 | 8,685 | SH | SOLE | 8,685 | 0 | 0 | ||
APTOSE BIOSCIENCES INC | COM NEW | 03835T200 | 896 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 7,343 | 105,828 | SH | SOLE | 105,828 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 260 | 56,500 | SH | SOLE | 56,500 | 0 | 0 | ||
AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 4,685 | 360,834 | SH | SOLE | 360,834 | 0 | 0 | ||
BAXTER INTL INC | COM | 071813109 | 489 | 5,800 | SH | SOLE | 5,800 | 0 | 0 | ||
BEAM THERAPEUTICS INC | COM | 07373V105 | 1,361 | 17,000 | SH | SOLE | 17,000 | 0 | 0 | ||
BRISTOL-MYERS SQUIBB CO | COM | 110122108 | 6,035 | 95,600 | SH | SOLE | 95,600 | 0 | 0 | ||
CARA THERAPEUTICS INC | COM | 140755109 | 2,171 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
CELLECTIS S A | SPON ADS | 15117K103 | 2,787 | 137,900 | SH | SOLE | 137,900 | 0 | 0 | ||
CUE BIOPHARMA INC | COM | 22978P106 | 6,793 | 556,777 | SH | SOLE | 556,777 | 0 | 0 | ||
ENCOMPASS HEALTH CORP | COM | 29261A100 | 8,190 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
EXICURE INC | COM | 30205M101 | 601 | 275,848 | SH | SOLE | 275,848 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 5,120 | 66,419 | SH | SOLE | 66,419 | 0 | 0 | ||
INOVALON HLDGS INC | COM CL A | 45781D101 | 2,446 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 4,472 | 750,310 | SH | SOLE | 750,310 | 0 | 0 | ||
LHC GROUP INC | COM | 50187A107 | 1,679 | 8,783 | SH | SOLE | 8,783 | 0 | 0 | ||
MEDTRONIC PLC | SHS | G5960L103 | 2,373 | 20,088 | SH | SOLE | 20,088 | 0 | 0 | ||
MEIRAGTX HLDGS PLC | COM | G59665102 | 4,213 | 291,944 | SH | SOLE | 291,944 | 0 | 0 | ||
METACRINE INC | COM | 59101E103 | 1,888 | 304,485 | SH | SOLE | 304,485 | 0 | 0 | ||
MORPHIC HLDG INC | COM | 61775R105 | 329 | 5,202 | SH | SOLE | 5,202 | 0 | 0 | ||
ODONATE THERAPEUTICS INC | COM | 676079106 | 402 | 117,621 | SH | SOLE | 117,621 | 0 | 0 | ||
ONCORUS INC | COM | 68236R103 | 986 | 70,807 | SH | SOLE | 70,807 | 0 | 0 | ||
ORGANOGENESIS HLDGS INC | COM | 68621F102 | 278 | 15,232 | SH | SOLE | 15,232 | 0 | 0 | ||
OSCAR HEALTH INC | CL A | 687793109 | 2,878 | 107,086 | SH | SOLE | 107,086 | 0 | 0 | ||
PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 2,976 | 450,165 | SH | SOLE | 450,165 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 15,072 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
SIO GENE THERAPIES INC | COMMON | 829399104 | 537 | 205,900 | SH | SOLE | 205,900 | 0 | 0 | ||
SOLID BIOSCIENCES INC | COM | 83422E105 | 1,770 | 320,100 | SH | SOLE | 320,100 | 0 | 0 | ||
UNITEDHEALTH GROUP INC | COM | 91324P102 | 2,232 | 6,000 | SH | SOLE | 6,000 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 8,241 | 38,350 | SH | SOLE | 38,350 | 0 | 0 | ||
ZIMMER BIOMET HOLDINGS INC | COM | 98956P102 | 3,393 | 21,197 | SH | SOLE | 21,197 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 3,806 | 195,000 | SH | SOLE | 195,000 | 0 | 0 |